Vimarsana
Biggest News Aggregation in the World

Page 26 - Immunic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Today - Breaking & Trending Today

DGAP-News: Immunic, Inc. to Participate in Investor and Scientific Conferences in February - Vimarsana News

DGAP-News: Immunic, Inc. to Participate in Investor and Scientific Conferences in February

DGAP-News: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor and Scientific Conferences in February 08.02.2022 / 12:30 The issuer is solely responsible

DGAP-News: Immunic, Inc. to Participate in Investor and Scientific Conferences in February - Vimarsana News

DGAP-News: Immunic, Inc. to Participate in Investor and Scientific Conferences in February

DGAP-News: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor and Scientific Conferences in February 08.02.2022 / 12:30 The issuer is solely responsible for the content of this announcement. Immunic, Inc. to Participate in Investor and Scientific Conferences in Febr...

Immunic, Inc. to Participate in Investor and Scientific Conferences in February - Vimarsana News

Immunic, Inc. to Participate in Investor and Scientific Conferences in February

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at...

Immunic, Inc. to Participate in Investor and Scientific Conferences in February - Vimarsana News

Immunic, Inc. to Participate in Investor and Scientific Conferences in February

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at...

DGAP-News: Immunic, Inc.: Immunic Receives Notice of Allowance for Composition-of-Matter Patents in the United States and in Europe for IMU-935, a Potentially Best-in-Class Oral IL-17 Inhibitor - Vimarsana News

DGAP-News: Immunic, Inc.: Immunic Receives Notice of Allowance for Composition-of-Matter Patents in the United States and in Europe for IMU-935, a Potentially Best-in-Class Oral IL-17 Inhibitor

DGAP-News: Immunic, Inc. / Key word(s): Patent Immunic Receives Notice of Allowance for Composition-of-Matter Patents in the United States and in Europe for IMU-935, a Potentially Best-in-Class